David C. Harmon
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Sarcoma Diagnosis and Treatment
- Oncology top 0.5%
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
Papers in
-
- Sarcoma Diagnosis and Treatment 56
- Oncology 34
- Vascular Tumors and Angiosarcomas 14
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Francis J. Hornicek (55 shared papers)Henry J. Mankin (36 shared papers)Edwin Choy (45 shared papers)Thomas F. DeLaney (33 shared papers)Herman D. Suit (13 shared papers)Andrew E. Rosenberg (17 shared papers)G. Petur Nielsen (16 shared papers)Zhenfeng Duan (15 shared papers)
- Journals
- Cancer (14 papers)International Journal of Radiation Oncology*Biology*Physics (14 papers)Journal of Clinical Oncology (12 papers)The Oncologist (5 papers)Journal of Orthopaedic Research® (5 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
David C. Harmon
127 papers receiving 7.3k citations
David C. Harmon's Hit Papers
Peers
Comparison fields: 5 of 111
- Pulmonary and Respiratory Medicine 4.1k
- Oncology 2.4k
- Rheumatology 1.3k
- Cancer Research 662
- Pathology and Forensic Medicine 773
Countries citing papers authored by David C. Harmon
This map shows the geographic impact of David C. Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Harmon more than expected).
Fields of papers citing papers by David C. Harmon
This network shows the impact of papers produced by David C. Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Harmon. The network helps show where David C. Harmon may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Harmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 Hit paper breakdown → | 2007 | 561 |
| 2 | 2009 | 259 | |
| 3 | 2004 | 259 | |
| 4 | 2003 | 244 | |
| 5 | 1988 | 227 | |
| 6 | 2007 | 220 | |
| 7 | 2008 | 213 | |
| 8 | 2011 | 210 | |
| 9 | 2006 | 207 | |
| 10 | 2014 | 176 | |
| 11 | 2005 | 163 | |
| 12 | 2014 | 157 | |
| 13 | 2004 | 149 | |
| 14 | 2007 | 141 | |
| 15 | 2011 | 132 | |
| 16 | 2014 | 126 | |
| 17 | 1988 | 115 | |
| 18 | 1984 | 111 | |
| 19 | 1988 | 107 | |
| 20 | 1997 | 104 |
About David C. Harmon
David C. Harmon is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Molecular Biology and Pathology and Forensic Medicine, having authored 131 papers that have together received 7.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (56 papers), Bone Tumor Diagnosis and Treatments (14 papers), Vascular Tumors and Angiosarcomas (14 papers), Lymphoma Diagnosis and Treatment (10 papers), Cardiac tumors and thrombi (8 papers), Soft tissue tumor case studies (7 papers), Blood disorders and treatments (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.1k citations), Oncology (2.4k citations), Rheumatology (1.3k citations), Cancer Research (662 citations) and Pathology and Forensic Medicine (773 citations). David C. Harmon has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Francis J. Hornicek, Henry J. Mankin, Edwin Choy, Thomas F. DeLaney, Herman D. Suit, Andrew E. Rosenberg, G. Petur Nielsen, Zhenfeng Duan, Robert G. Maki and Mark C. Gebhardt. Their work appears in journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, The Oncologist and Journal of Orthopaedic Research®.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.